Definitive Contract W911SR23C0022

Award Date 8/4/23
Potential Completion Date 8/4/25
Potential Value $1.1M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02138, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC, a small business limited liability company, under the Small Business Innovation Research (SBIR) Program Phase I. The $149,972.66 firm fixed-price purchase order is for research and development services in support of chemical and biological defense programs. As a prime contractor, Clear Scientific has previously provided drug...
This is a $167,351.40 firm fixed-price purchase order contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Clear Scientific, LLC, a small business limited liability company. The contract is for ARMY SBIR PHASE I research and development services, which are likely focused on supporting chemical and biological defense research efforts, as well as general pharmaceutical and medical research programs. Clear Scientific has prior...
The Department of the Army Materiel Command Research Development and Engineering Command awarded a Firm Fixed Price Definitive Contract to Clear Scientific, LLC, a for-profit limited liability company. The $149,797.88 contract was awarded under the Small Business Innovation Research (SBIR) Program Phase I, which supports early-stage research and development. Clear Scientific, a small business, will provide research and development services in support of the agency's chemical and biological...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a small business limited liability company. The contract, valued at $167,474.81, is for research and development services in support of pharmaceutical, medical, and defense programs. Clear Scientific has previously received prime contract awards and subcontracts from the Department of Defense and...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a for-profit limited liability company. The $999,613.38 Firm Fixed Price contract supports research and development of drug formulations, quality control, and analytical testing services primarily for pharmaceutical, medical, and defense programs. Clear Scientific has prior experience providing...
Clear Scientific, LLC has been awarded a definitive contract valued at approximately $1.1 million by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to provide monthly progress reports in support of Research Type SBIR Program Phase II Action. The two-year firm fixed price contract, which has a total small business set-aside designation, will be performed by Clear Scientific in Cambridge, Massachusetts. No additional details were provided on the...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded a definitive contract valued at $999,888.84 to Clear Scientific, LLC for Phase II - Base Year research as part of the Small Business Innovation Research (SBIR) Program Phase II Action. The place of performance will be Cambridge, MA and the contract period runs from September 26, 2022 through September 30, 2024. This firm fixed price contract was set aside for total small...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a small business limited liability company. The contract has a total potential value of $167,446.37 and is a Firm Fixed Price definitive contract for STTR (Small Business Technology Transfer) Phase I research. The contract is set aside for small businesses. Clear Scientific provides research,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Clear Scientific, LLC, a for-profit limited liability company. The $167,420.88 firm fixed-price contract is for the development of colorometric detection inks that can be printed using off-the-shelf inkjet cartridges to detect hazardous compounds. This research supports the agency's chemical and biological defense programs. As...
This is a $111,229.44 firm-fixed-price purchase order awarded by the Defense Health Agency to Clear Scientific, LLC, a for-profit limited liability company. The contract is for drug formulation, quality assurance/quality control, method development, and sample analysis services to support pharmaceutical, medical, and defense programs. Clear Scientific has previously provided similar services as a prime contractor and subcontractor to the Department of Defense and Department of the Army. The...

This is a $1,099,504.56 firm-fixed-price contract awarded by the Joint PEO Chemical and Biological Defense, a part of the U.S. Army, to Clear Scientific, LLC, a small business. The contract is for a Phase II SBIR (Small Business Innovation Research) effort, with an ultimate completion date of August 4, 2025. Clear Scientific, LLC is a small business that provides research, development, manufacturing, and analytical services to U.S. federal agencies, primarily in support of pharmaceutical, medical, and defense programs. This contract award is likely to support the company's ongoing work in developing therapeutic agents for treating opioid and methamphetamine intoxication and overdose, which has been funded through past grants from the National Institutes of Health.

Generated 8/25/24, 12:39 AM